Alteration of tumor markers may predict survival in colorectal cancer patients treated with TAS-102 or regorafenib as salvage-line chemotherapy: a single-institutional experience
Keiji Matsuda; Keijiro Nozawa; Kohei Ohno; Yuka Okada; Takahiro Yagi; Mitsuo Tsukamoto; Yoshihisa Fukushima; Takuya Akahane; Atsushi Horiuchi; Ryu Shimada; Tamuro Hayama; Koichi Okamoto; Takeshi Tsuchiya; Junko Tamura; Hisae Iinuma; Yuko Sasajima; Fukuo Kondo; Shoichi Fujii; Yojiro Hashiguchi
Biomedical Research and Clinical Practice 2 2 1 - 5 2017年
[査読有り]